ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

MGX // Metagenomi Therapeutics Inc.

DIV <GO> NASDAQ RQD COCKPIT → CIK 0001785279 ↗
Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$0.83 ▲ +0.01 (+1.03%)
MKT CAP: $31.4M • VOL: 72.0K
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
MGX // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>) SPOT: $0.83
Metagenomi Therapeutics Inc. (MGX) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (-35.0% ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).